CIK: 0001617201 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 14, 2018
Total Value ($000): $159,449 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SHIRE PLC | 146,114 | $21,828 | 13.7% | $149.39 | — | SPONSORED ADR | 82481R106 |
| — | ALLERGAN PLC | 94,800 | $15,954 | 10.0% | $163.58 | — | SHS | G0177J108 |
| MGNX | MACROGENICS INC | 445,000 | $11,196 | 7.0% | $18.67 | +30.1% | COM | 556099109 |
| SBRA | SABRA HEALTH CARE REIT INC | 580,000 | $10,237 | 6.4% | $18.43 | — | COM | 78573L106 |
| — | ACHAOGEN INC | 661,054 | $8,561 | 5.4% | $11.04 | — | COM | 004449104 |
| — | TELIGENT INC NEW | 2,472,561 | $8,308 | 5.2% | $3.36 | — | COM | 87960W104 |
| — | ALMOST FAMILY INC | 135,000 | $7,560 | 4.7% | $55.57 | — | COM | 020409108 |
| — | REATA PHARMACEUTICALS INC | 297,750 | $6,107 | 3.8% | $25.04 | — | CL A | 75615P103 |
| — | CIGNA CORPORATION | 32,200 | $5,401 | 3.4% | $167.73 | — | COM | 125509109 |
| — | SIERRA ONCOLOGY INC | 2,538,525 | $5,255 | 3.3% | $2.07 | — | COM | 82640U107 |
| — | EIGER BIOPHARMACEUTICALS INC | 530,848 | $5,229 | 3.3% | $13.95 | — | COM | 28249U105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 63,400 | $5,140 | 3.2% | $85.82 | 0.0% | COM | 09061G101 |
| DXCM | DEXCOM INC | 65,000 | $4,820 | 3.0% | $13.93 | +6.2% | COM | 252131107 |
| — | ARENA PHARMACEUTICALS INC | 120,400 | $4,756 | 3.0% | $39.50 | — | COM NEW | 040047607 |
| — | CIDARA THERAPEUTICS INC | 1,186,355 | $4,746 | 3.0% | $6.80 | — | COM | 171757107 |
| — | PIERIS PHARMACEUTICALS INC | 563,763 | $3,845 | 2.4% | $6.82 | — | COM | 720795103 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 209,842 | $3,546 | 2.2% | $8.03 | +88.6% | COM | 462260100 |
| — | INOGEN INC | 26,800 | $3,292 | 2.1% | — | — | Put | 45780L954 |
| — | QUOTIENT LTD | 682,180 | $3,213 | 2.0% | $4.95 | — | SHS | G73268107 |
| — | AVEO PHARMACEUTICALS INC | 1,043,550 | $3,026 | 1.9% | $2.79 | — | COM | 053588109 |
| — | CLOVIS ONCOLOGY INC | 50,000 | $2,640 | 1.7% | — | — | Call | 189464900 |
| — | CIVITAS SOLUTIONS INC | 164,396 | $2,532 | 1.6% | $15.40 | — | COM | 17887R102 |
| CNC | CENTENE CORP DEL | 23,375 | $2,498 | 1.6% | $48.44 | +7.6% | COM | 15135B101 |
| — | CLOVIS ONCOLOGY INC | 46,001 | $2,429 | 1.5% | $66.02 | — | COM | 189464100 |
| — | PARATEK PHARMACEUTICALS INC | 148,682 | $1,933 | 1.2% | $17.90 | — | COM | 699374302 |
| — | KINDRED HEALTHCARE INC | 162,326 | $1,485 | 0.9% | $9.15 | — | COM | 494580103 |
| — | NABRIVA THERAPEUTICS PLC | 242,689 | $1,221 | 0.8% | $5.98 | — | SHS | G63637105 |
| — | NOVELION THERAPEUTICS INC | 233,003 | $816 | 0.5% | $3.12 | — | COM NEW | 67001K202 |
| QURE | UNIQURE NV | 34,100 | $801 | 0.5% | $15.23 | +43.2% | SHS | N90064101 |
| — | BELLICUM PHARMACEUTICALS INC | 106,050 | $696 | 0.4% | $8.41 | — | COM | 079481107 |
| — | AMPIO PHARMACEUTICALS INC | 111,150 | $378 | 0.2% | $3.40 | — | COM | 03209T109 |